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Objectives: Posterior circulation ischemic stroke (PCIS), accounting for approximately 20% of
total ischemic stroke, is a sever disease that associated with high rate of morbidity and
mortality. Though the effectiveness of endovascular mechanical thrombectomy has been
well demonstrated in many types of ischemic stroke, it is still unclear what the outcome is in
posterior circulation ischemic stroke.
Methods and materials: In current study, data was collected from 139 Chinese patients who
received endovascular mechanical thrombectomy treatment with Solitaire device after
acute posterior circulation ischemic stroke. We measured the mortality, symptomatic
intracranial hemorrhage (SICH) and National Institutes of Health Stroke Scale (NIHSS) to
evaluate the safety of endovascular mechanical thrombectomy. Meanwhile, the clinical
outcome of endovascular mechanical thrombectomy was also evaluated based on recana-
lisation rate, HIHSS, and the modiﬁed Rankin Scale (mRS).
Results: Recanalisation was successful in 124 (89.3%) patients after surgery. Herniation was
the second fatal stroke complication, out of the 6 patients suffered from herniation, 3
patients (50%) died during surgery and 2 (33%) died after surgery. As for other stroke
complications such as pulmonary infection, 1 patient (4.3%) died during surgery and 1
patient (4.3%) died 3 days after surgery.
Conclusion: Our ﬁndings indicate that endovascular mechanical treatment is a safe treat-
ment which brings clear beneﬁt to patients suffered from posterior circulation ischemic
stroke, in both the recanalisation rate and functional outcomes.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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Acute basilar artery occlusion (BAO) caused the most severe
types of ischemic stroke, without active treatment, the
mortality rate can be up to 90% [1,2]. Anterior and posterior
circulations were two important artery systems supplied by
basilar artery. Based on the location where infarction occurred
within the vascular territory, BAO could lead to anterior or
posterior circulation ischemic stroke [1,3]. The two differs from
both stroke etiology [4,5] and in terms of morbidity and
mortality rate [6].
Although rarer than anterior circulation ischemic stroke
(ACIS), posterior circulation ischemic stroke (PCIS) accounts
for approximately 20% of all ischemic stroke [1,7–9], and
without proper treatment, it might leads to potentially
preventable death or severe disability [10].
Thrombolysis is an effective medical therapy for PCIS
patients, however, with a strictly limited time window. Based
on series of randomized large sample clinical studies,
intravenous tissue-type plasminogen activator (tPA) must be
applied within up 4.5 h of symptom onset [11–13].
Multiple recent studies showed consistent results that
endovascular mechanical thrombectomy, a technique which
clears local thrombosis by mechanical methods, can bring a
clear beneﬁt to acute anterior circulation ischemic stroke
(ACIS) patients, with a prolonged treatment window [14–18].
Moreover, the combination of tPA treatment with endovas-
cular mechanical thrombectomy had largely facilitated artery
recanalisation of ischemic stroke patients [14,19,20]. Most of
the studies were based on data from single center or a limited
number of patients with acute ACIS [21–26]. PCIS differs from
ACIS in terms of both stroke etiology [4,25] and higher rate of
morbidity and mortality [6]. Evidence is needed to evaluate the
clinical outcomes of endovascular mechanical thrombectomy
on PCIS patients.
We undertook the current multicenter, retrospective study
with large sample size on the effectiveness of endovascular
mechanical thrombectomy on PCIS patients. We collected theFig. 1 – pc-ASPECTS score: the three figures showed examples o
figures.data of 139 Chinese patients suffering from posterior circula-
tion stroke in the database of Acute Cerebrovascular Disease
(http://www.acute-cvd.com), analyzed and evaluated the
clinical outcomes of these patients treated within 24 h after
stroke onset. Both the safety and efﬁcacy of endovascular
mechanical thrombectomy with Solitare device, one of the
most effective recanalisation devices [27,28], on these patients,
and the related clinical prognostic factors 90 days after
treatment were analyzed.
2. Methods
2.1. Patient population
We collected data of 139 Chinese patients suffered acute
ischemic stroke and received hospitalization in multiple
centers located in China from January 2012 to December
2015. All data were acquired from the database of Acute
Cerebrovascular Disease (http://www.acute-cvd.com). From
the total 643 patients in the database, with either anterior (500
cases) or posterior (140 cases) circulation ischemic stroke, we
selected patients based on the following criteria: (1) diagnosed
as acute posterior circulation ischemic stroke, with Digital
Subtraction Angiography (DSA) to conﬁrm the location of
occlusion; (2) aging from 18 to 80 years old; (3) baseline
National Institutes of Health Stroke Scale (NIHSS) ≥ 8; (4)
Thrombolysis In Cerebral Infarction (TICI) is between 0 and 1, a
criteria proposed by Solitaire device for patients to receive
endovascular mechanical thrombectomy, assessed by Com-
puted Tomography Angiography (CTA), Magnetic Resonance
Angiography (MRA) or Digital Subtraction Angiography (DSA);
(5) accumulated Alberta Stroke Program Early CT Score
(ASPECTS) ≥ 6 and the pons–mesencephalon score 0–2 (see
Fig. 1); (6) received endovascular treatment within 24 h after
stroke onset. Although most patients suffered only basilar
artery occlusion, there were some cases where vertebral artery
or the posterior cerebral artery occlusion was observed.f pons–mesencephalon score from 0 to 2, as indicated in the
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All the patients received endovascular mechanical thromb-
ectomy treatment under anesthesia. The surgery procedure
includes following steps.
After femoral artery puncture, whole-brain vessels angiog-
raphy was performed to locate the blocked artery and to
conﬁrm the perfusion state of its neighboring vessels (TICI
scales). A microcatheter was penetrated through the thrombus
to perform superselectire angiography, in order to conﬁrm the
length of the thrombus and the perfusion state of the vessel
distal to the thrombus.
To perform the endovascular mechanical thrombectomy,
an 8-F guiding catheter was located at the proximal end of the
thrombus through transfemoral access. Then a Rebar18
microcatheter was carefully navigated through the thrombus
over a 0.014-in. microwire to reach the distal end of the
thrombus (Fig. 2, up left). The end of the stent retriever was left
several millimeters farther than the distal end of the
thrombus. Then the microcatheter was withdrawn back to
the proximal end of the thrombus and the stent retriever was
allowed to fully expand all through the thrombus (Fig. 2, up
right). While keeping its fully expanded status, the stent
retriever was carefully pulled back to recanalise the occluded
artery (Fig. 2, down left). The end of the guiding catheter was
opened and the thrombus fragments along with the stent
retriever were sucked out by a 50 ml syringe (Fig. 2, down right).
Imaging was followed immediately to conﬁrm the artery
recanalisation.
After surgery, the patients were administered with a dual
dose of 75 mg clopidogrel and 100 mg aspirin for antiplatelet
treatment.
2.3. Variables of interest
2.3.1. Safety evaluation
The safety of endovascular mechanical thrombectomy was
evaluated by the following variables: (1) mortality rate 90 daysFig. 2 – Endovascular mechanical thrombectomy by Solitaire
device. Up left: 0.014-in. microwire to reach the distal end
of the thrombus. Up right: microcatheter withdrawn back
to the proximal end of the thrombus and the stent retriever
fully expand all through the thrombus. Down left: stent
retriever was carefully pulled back to recanalise the
occluded artery. Down right: guiding catheter end opened
and the thrombus fragments sucked out by a 50 ml syringe.after surgery; (2) the rate of symptomatic intracranial
hemorrhage (SICH). The judgment of SICH was based on the
evidence of CT or MRI. SICH was deﬁned as the intracranial
hemorrhage within 22–36 h after treatment as conﬁrmed by
imaging techniques, accompanied with NIHSS decrease ≥ 4.
2.3.2. Effectiveness evaluation
The effectiveness of endovascular mechanical thrombectomy
was evaluated as the recanalisation rate, represented by TICI (2
or 3). Besides, the NIHSS score at discharge and 90 days after
endovascular mechanical thrombectomy surgery were ana-
lyzed. Modiﬁed Rankin Scale (mRS) 90 days post surgery was
measured. The complications such as symptomatic intracere-
bral hemorrhage, vessel dissection and the occlusion of
unaffected vessels were monitored as well.
2.3.3. Factors affecting clinical outcomes
We monitored the factors that could potentially affect clinical
outcomes, including (1) factors related with patients: (i) age, (ii)
baseline blood pressure, (iii) diabetes, (iv) NIHSS or GCS before
treatment; (2) factors related with endovascular mechanical
thrombectomy: (i) anesthesia, (ii) number of endovascular
mechanical thrombectomy received, (iii) length of time from
arriving hospital to recanalisation, (iv) type of stroke (TOAST
classiﬁcation), (v) combined treatment regime, (vi) symptom-
atic hemorrhage.
2.4. Statistical analysis
Descriptive analysis on frequencies or percentages of classi-
ﬁed variables was performed. Chi-square test was performed
on continuous variables that ﬁt normal distribution. For the
continuous variables that did not ﬁt normal distribution,
median and quartile values were used for analysis. To
compare patients with favorable vs. unfavorable prognosis,
t-test or rank sum test was performed on the continuous
variables, while chi-square test or Fisher exact probability test
was performed on classiﬁed variables. One-way analysis of
variance (ANOVA) was performed on factors predicting the
change of clinical phase. All the analysis was performed on
software SPSS 19.0.
3. Results
3.1. Patient data
In this study, we collected data of 139 Chinese patients
suffered acute ischemic stroke and received endovascular
mechanical recanalisation from the database of Acute
Cerebrovascular Disease (http://www.acute-cvd.com). In our
collection, there were 105 male and 34 female patients, with an
average age of 59.7  13.6. The median pre-thrombectomy
NIHSS score was 23 (IQR: 16–28) and the median pre-thromb-
ectomy GCS was 9 (IQR: 7–10) (Table 1).
3.2. Treatment results and clinical outcomes
In current dataset, the median onset-to-door time was 310
(IQR: 240–498) min and the median surgery time was 72 (IQR:
Table 1 – Patient characteristics.
Characteristics Value
Number of patients 139
Male (%) 105 (75.5)
Age (year), mean (SD) 59.7 (13.6)
Pre-thrombectomy NIHSS, median (IQR) 23 (16–28)
Pre-thrombectomy GCS, median (IQR) 9 (7–10)
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rate: 10%) and the mortality rate reached 14.3% (20/139) by the
time of 90 days after surgery. Favorable outcomes (mRS scores:
0–2) were achieved in 34 patients at discharge (24.5% of all the
patients, 27.2% of the survivors). By the time of 90 days after
surgery, favorable outcomes (mRS scores: 0–2) were achieved
in 58 patients (41.7% of all the patients, 48.7% of the survivors).
The patients' median post-thrombectomy NIHSS score was
17.0 (IQR: 7.5–24.5) at discharge after endovascular mechanical
thrombectomy surgery. Recanalisation was successful in 124
patients (89.2%) with TICI grades ≥ 2b; furthermore, 62.1% of
these patients achieved TICI grade 3. By the time of 90 days
after surgery, the median NIHSS score was 10.0 (IQR: 4.8–20.0)
(Table 2). Endovascular mechanical thrombectomy surgery
with Solitaire device had improved NIHSS score signiﬁcantly,
both at discharge (P < 0.0001) and 90 days after surgery
(P < 0.0001).
However, seven kinds of stroke complications were
observed in the patients during or after surgery: 23 patients
(16.5%) suffered from pulmonary infection, 5 patients (3.6%)
suffered from hemorrhagic transformation, 6 patients (4.3%)
suffered from herniation, 1 patient (0.7%) suffered from
hydrocephalus, 1 patient (0.7%) suffered from gastrointestinal
hemorrhage, 4 patients suffered from cardiac or respiratory
arrest (2.9%) and 1 patient (0.7%) suffered from recurrent stroke
(Table 2).Table 2 – Treatment outcomes.
Characteristics Value
Onset-to-door time (min), median (IQR) 310 (240–498)
Surgery time (min), median (IQR)
TICI after surgery, n (% of all, % of survivors)
72 (50–120)
≥2b 124 (89.2, 99.2)
3 77 (55.4, 61.6)
NIHSS at discharge, median (IQR) 17.0 (7.5–24.5)
mRS at discharge, n (% of all, % of survivors)
0–2 34 (24.5, 27.2)
Mortality at discharge, n (%) 14 (10)
NIHSS 90 days after surgery, median (IQR) 10.0 (4.8–20.0)
mRS 90 days after surgery, n
(% of all, % of survivors)
0–2 58 (41.7, 48.7)
Mortality 90 days after surgery, n (%) 20 (14.4)
Stroke complications, n (%)
Pulmonary infection 23 (16.5)
Hemorrhagic transformation 5 (3.6)
Herniation 6 (4.3)
Hydrocephalus 1 (0.7)
Gastrointestinal hemorrhage 1 (0.7)
Cardiac or respiratory arrest 4 (2.9)
Recurrent stroke 1 (0.7)4. Discussion
Endovascular mechanical thrombectomy with a stent retriever
was now the most recommended treatment in patients
suffered from BAO of anterior cerebral circulation [14–18].
However, on the other hand, there were only a few small
sample studies focusing on the safety and effectiveness of
endovascular mechanical thrombectomy treatment on
patients suffered from acute posterior circulation ischemic
stroke, another important stroke type caused by BAO [22,29–
32]. To the best of our knowledge, this study was the ﬁrst
multi-center study with large sample size to evaluate the
safety and effectiveness of endovascular mechanical thromb-
ectomy treatment with Solitaire device on acute posterior
circulation ischemic stroke on 139 Chinese patients.
Our study showed improved outcomes of endovascular
mechanical thrombectomy treatment with Solitaire device on
patients suffered from acute posterior circulation ischemic
stroke than reported results with either traditional treatment
[2] or thrombolysis therapy [33,34] in the following aspects:
reduced mortality rate, higher recanalisation rate and better
clinical outcomes. As compared with traditional treatment,
our mechanical thrombectomy treatment with Solitaire device
showed a much lower mortality rate (10% after surgery and
14.3% by 90 days vs. traditional 40%) as well as improved
outcomes (34% at mRS 0–2 vs. traditional 17% at mRS 0–3) [2].
By 90 days after treatment, our method showed an even better
outcome (58% at mRS 0–2) than that with traditional
treatment. As compared with another widely used treatment
for ischemic stroke, thrombolysis therapy, our method
achieved a higher recanalisation rate (89.2% vs. 53–65%)
[33,34]. All these results suggest that mechanical thrombec-
tomy with Solitaire device could serve as a safe and efﬁcient
treatment for patients suffered from acute posterior circula-
tion ischemic stroke, which could provide better outcomes
than traditional treatment or thrombolysis therapy. Further-
more, even when compared with mechanical thrombectomy
treatment with other devices, such as Merci device, our
mortality rate with Solitaire device was much lower (10% after
surgery and 14.3% by 90 days vs. 43–50% with Merci) along with
a much shorter operation time (73 with Solitaire vs. 129 min
with Merci) [40]. Our operation time was comparable to a
recent single center study with Solitaire device (73 vs. 61 min),
but with a lower mortality rate (14.3 vs. 32%) [22]. These results
suggest that both our treatment strategy and operation
techniques are competent to the best level of mechanical
thrombectomy.
In current study, stroke complications during and after
surgery have a strong correlation with after surgery mortality
(65% of the 20 deaths). Cardiac or respiratory arrest was the
most fatal stroke complication and all four patients suffered
from it died during surgery (100%). Herniation was the second
fatal stroke complication, out of the six patients suffered from
herniation, three (50%) died during surgery and two (33%) died
after surgery. As for other stroke complications such as
pulmonary infection, one patient (4.3%) died during surgery
and one patient (4.3%) died three days after surgery. Two
patients suffered from hemorrhagic transformation (40%) died
during surgery. Developing strategies to monitor and reduce
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 2 0 8 – 2 1 3212stroke complications is a potential target to further improve
the safety and efﬁcacy of mechanical thrombectomy treat-
ment on acute posterior circulation ischemic stroke patients.
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